(Source: Business Wire)

ICON (NASDAQ:ICLR)(ISIN:IE0005711209), a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries, today reported its financial results for its third
quarter ended September 30, 2009.
Net revenues for the quarter were $220.3 million, representing a 2.3%
decrease over net revenues of $225.5 million for the comparative quarter
last year. On a constant organic dollar basis revenues were similar to
prior year. Year-to-date, net revenues were $660.2 million, representing
a 2.3% increase over the same period last year.
Income from operations increased by 12% to $30.4 million, compared to
$27.1 million for the same quarter last year. Operating margin increased
to 13.8% from 12%. Net income was $24 million, compared with $21.4
million last year an increase of 12%. EPS of 40 cents per share on a
diluted basis represented an increase of 14% over 35 cents per share
last year.
Year-to-date income from operations, before one time net charges, was
$86.6 million, compared to $73.0 million last year representing an
operating margin increase to 13.1% from 11.3%. Net income before one
time net charges was $67.7 million or $1.13 per share, compared with
$57.1 million or 93 cents per share last year representing an increase
in EPS of 22%.
Days sales outstanding, comprising accounts receivable and unbilled
revenue less payments on account, were 39 days at September 30, 2009,
compared to 69 days at December 31, 2008.
For the quarter ended September 30, 2009, cash provided by operating
activities was $70 million and capital expenditure was $9.6 million. As
a result, the company's net cash amounted to $145 million at September
30, 2009, compared to net debt of $4.3 million at December 31, 2008.
Chairman Dr. John Climax commented "I am very pleased with ICON's
performance for the first nine months of 2009. Our growth in margins,
operating income and earnings was very encouraging. Year to date
earnings per share were up 22% over the first nine months of 2008."
"Despite the economic and industry headwinds," said CEO Peter Gray "ICON
has continued to improve margins, grow earnings and significantly
improve cashflows enabling us to again raise earnings guidance for 2009.
While higher than normal cancellations held back net business awards,
the levels of business opportunity continue to be strong and we remain
optimistic for the future".
The company will hold its third quarter conference call today, October
21, 2009 at 9:00 EST [14:00 Ireland & UK]. This call and linked slide
presentation can be accessed live from our website at http://www.iconplc.com.
A recording will also be available on the website for 90 days following
the call. In addition, a calendar of company events, including upcoming
conference presentations, is available on our website, under
"Investors". This calendar will be updated regularly.
In addition to the financial measures prepared in accordance with
generally accepted accounting principles (GAAP), this press release
contains certain non-GAAP financial measures, including non-GAAP
operating and net income and non-GAAP diluted earnings per share. While
non-GAAP financial measures are not superior to or a substitute for the
comparable GAAP measures, ICON believes certain non-GAAP information is
useful to investors for historical comparison purposes.
The statements made in this Press Release may contain forward-looking
statements that involve a number of risks and uncertainties. In addition
to the matters described in this Press Release, the ability to maintain
large client contracts or enter into new contracts, maintain client
relationships and the ability to manage the opening of new offices, the
integration of new business mergers and acquisitions, as well as other
risks and uncertainties detailed from time to time in SEC reports filed
by ICON, including its Form 20-F, F-1, S-8 and F-3, may affect the
actual results achieved by ICON. ICON disclaims any intent or obligation
to update these forward-looking statements.
ICON plc is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The Company
specialises in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON
currently, operates from 68 locations in 38 countries and has
approximately 7,000 employees. Further information is available at www.iconplc.com.
Source: ICON plc
Exception caught in main.
ICON plc
Consolidated Income Statements (Unaudited) (US GAAP)
Three and Nine Months ended September 30, 2009 and September 30, 2008
(Dollars, in thousands, except share and per share data)
Three Months Ended Nine Months Ended
September 30, September 30, September 30, September 30,
2009 2008 2009 2008
Gross Revenue 317,179 313,637 936,686 914,082
Reimbursable expenses 96,818 88,126 276,493 268,927
Net Revenue 220,361 225,511 660,193 645,155
Costs and expenses
Direct costs 127,179 127,948 376,493 364,113
Selling, general and administrative 54,369 62,494 173,637 187,328
Depreciation and amortization 8,404 7,937 23,420 20,676
One -- time net charges - - 8,941 -
Total costs and expenses 189,952 198,379 582,491 572,117
Income from operations 30,409 27,132 77,702 73,038
Interest expense (693) (224) (2,304) (743)
Income before provision for income taxes 29,716 26,908 75,398 72,295
Provision for income taxes 5,765 5,355 11,973 14,493
Minority interest - 173 - 707
Net income 23,951 21,380 63,425 57,095
Net income per ordinary share
Basic $0.41 $0.37 $1.08 $0.98
Diluted $0.40 $0.35 $1.06 $0.93
Weighted average number of ordinary shares
Basic 58,624,028 58,451,960 58,579,402 58,156,869
Diluted 59,953,574 61,847,265 59,781,092 61,357,893
-------------------------------------------------------------------------------
ICON plc
Summary Balance Sheet Data
September 30, 2009 and December 31, 2008
(Dollars, in thousands)
September 30, December 31,
2008 2008
(Unaudited) (Audited)
Cash and short-term investments 172,872 101,104
Debt (28,270) 105,379
Net cash/(debt) 144,602 (4,275)
Accounts receivable 191,962 210,535
Unbilled revenue 118,398 141,727
Payments on account (172,699) (121,935)
Total 137,661 230,327
Working Capital 215,658 185,957
Total Assets 922,140 867,285
Shareholder's Equity 540,854 456,366
Source: ICON plc
Contact: Investor Relations 1-888-381-7923 or
Ciaran Murray CFO + 353 1 291 2000
Brendan Brennan Corp FP&A + 353 1 291 2000
all at ICON.
http://www.iconplc.com
-------------------------------------------------------------------------------
ICON/ICLR-F
A service of YellowBrix, Inc.